Isabella Young Receives the 2023 CROI New Investigator Award
At the 2023 Conference on Retroviruses and Opportunistic Infections (CROI), Isabella Young was awarded the 2023 New Investigator Award. She met Dr. Fauci in person and presented her work to attendees. Congrats Isabella!
January 2022 – Jasmine King receives prestigious NIH T32 Fellowship in collaboration with UNC/Duke Clinical Pharmacology Program!
Congrats Jasmine!
January 2022 – Ally Thorson receives Lucas Scholarship Award! Congrats Ally!
The program was named to honor UNC’s Biomedical Engineering Department founding chair, Dr. Carol Lucas, and also to recognize her contributions to the field of biomedical engineering.
December 2021 – Isabella Young receives New Investigator Scholarship at Conference of Retroviruses and Opportunistic Infections Annual Meeting (CROI 2022)
November 2021 – Aryani Pallerla receives Male Contraceptive Initiative Award! Congrats Aryani!
In 2021, MCI’s Youth Advisory Board (YAB) was able to release an undergraduate research opportunity in an effort to engage young scholars in the field of male contraception. The opportunity was made available with support from the Parsemus Foundation and contributions from Male Contraceptive … Read more
July 2021 – Isabella Young receives MSD/IAS Prize for Research in HIV Prevention at International AIDS Society Meeting!
Congrats Isabella!
New Exciting R01 Grant to Develop a First-in-line Injectable MPT for Prevention of HIV & Unplanned Pregnancy!
The lab of Rahima Benhabbour, PhD, has received a $3.74 million grant over five years from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The grant will fund the creation of an … Read more
Jasmine King Receives the HHMI Gilliam Fellowship Award!
Congrats Jasmine!!!
Jasmine King Receives a Prestigious EII $25K Grant!
Congrats Jasmine on this terrific achievement!
Isabella Young Receives a Prestigious NSF Predoctoral Fellowship Award & Honorable Mention for the Ford Foundation!
Congrats Isabella!!!
Carolina Awarded $2.91 Million to Create New Ultra-long-acting HIV Drug Delivery Implant
HIV clinical trials have shown that the protective efficacy of daily antiretroviral drugs for the prevention of HIV transmission correlates with adherence – whether an uninfected person takes the prescribed medication at proper times. But nonadherence is a major roadblock toward decreasing the spread of HIV. One solution to the adherence problem is to make drug delivery less frequent but no less effective.